Alfredo Carrato

Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC

Affiliated withInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC Ramón y Cajal Health Research Institute (IRYCIS)the Biomedical Research Network in Cancer (CIBERONC)

Research Area

Cancer Research

Biography

Alfredo Carrato has not added Biography.
If you are Alfredo Carrato and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 3	2019
Publication title Cited by 5	2023

Other Publications

Article	Year
Anti-VEGF therapy: a new approach to colorectal cancer therapy. Expert review of anticancer therapy\| PubMed ID: 17069524	2006
Capecitabine plus oxaliplatin for the treatment of colorectal cancer. Expert review of anticancer therapy\| PubMed ID: 18279056	2008
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 19574202	2009
Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib. Anti-cancer drugs\| PubMed ID: 20110785	2010
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23358972	2013
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 23359181	2013
The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies. BMC genomics\| PubMed ID: 25997541	2015
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. BMC cancer\| PubMed ID: 26498594	2015
Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies. BMC genomics\| PubMed ID: 26621286	2015
Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens. Cancer treatment reviews\| PubMed ID: 27676174	2016
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 27995549	2017
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD). European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28633089	2017
A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds. Micromachines\| PubMed ID: 30424062	2018
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs. Cancers\| PubMed ID: 30862091	2019
Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys". International journal of molecular sciences\| PubMed ID: 30999623	2019
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). BMC cancer\| PubMed ID: 31159765	2019
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms. International journal of molecular sciences\| PubMed ID: 31597249	2019
A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine\| PubMed ID: 32113160	2020
Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic ... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 32977220	2020
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 34363594	2022
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 35316750	2022